Drugs / Monosialoganglioside Ganglioside
last change Sep 2019 re-read 2 minutes ago

Monosialoganglioside Ganglioside

Developed for
radiation-induced disorder
Investigated by
Zhejiang Cancer Hospital

Trials 1 · a red edge is where a trial was stopped

2017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03067753 Dec 2016 → Sep 2019 radiation-induced disorder Zhejiang Cancer Hospital Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Monosialoganglioside Ganglioside ClinicalTrials.gov intervention name — accepted as the source's own label NCT03067753